Into the twilight zone - should ER-low breast cancer be treated as triple negative breast cancer?
| Autor: | Jernström H; Department of Clinical Sciences Lund, Oncology, Lund University, Lund, Sweden.; Lund University Cancer Centre (LUCC) and Skåne University Hospital Comprehensive Cancer Center (SUHCC), Sweden., Rydén L; Lund University Cancer Centre (LUCC) and Skåne University Hospital Comprehensive Cancer Center (SUHCC), Sweden.; Department of Clinical Sciences Lund, Surgery, Lund University and Skåne University Hospital, Lund, Sweden. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | The Lancet regional health. Europe [Lancet Reg Health Eur] 2024 Apr 01; Vol. 40, pp. 100896. Date of Electronic Publication: 2024 Apr 01 (Print Publication: 2024). |
| DOI: | 10.1016/j.lanepe.2024.100896 |
| Abstrakt: | Competing Interests: Helena Jernström and Lisa Rydén declare no conflict of interest. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|